
Sign up to save your podcasts
Or


Based on Podcast App listening data
Precision Hormone Health: Testosterone, Menopause, Muscle, Sleep, and Proactive Longevity: Endocrinologist Dr. Florence Comite details her book “Invincible: Defy Your Genetic Destiny to Live Better, Longer” and her precision-medicine approach to proactive longevity. She discusses testosterone decline beginning in the 30s in both sexes, stress-related low T (including in special forces), and testosterone’s roles in energy, cognition, motivation, muscle, bone, and chronic disease risk. Comite argues genes are a “draft” and health destiny can be altered through epigenetic-like choices, individualized data, and early monitoring. For women, she emphasizes estrogen, progesterone, and testosterone in perimenopause/menopause, preferring bioidentical hormones and criticizing WHI’s use of Premarin/Provera and older participants. She covers osteoporosis prevention, muscle as an “organ of longevity,” protein intake, resistance training, continuous glucose monitors for individualized diet, sleep quality tracking via wearables, and selective use of DHEA, pregnenolone, growth hormone pathways, and peptides with attention to sourcing and risk.
Dr. Hoffman continues his conversation with endocrinologist Dr. Florence Comite.
Life is longer for “those who think young”; Watching too much TV may shrink your brain (literally!); Diet and supplements may help lupus; When a high-fiber diet before surgery may be inadvisable; Your mouth may be the gateway to your overall health and longevity.
Advantages of time-restricted eating for body and brain; Dermatologist tells her patient to stay away from hair supplements; Do you still need colonoscopies past 75? How much NTFactor should you take? Breathing CO2 clears brain of amyloid plaque; Popular AI diet tracking apps may underestimate by as much as 345 calories; A novel treatment for knee pain—fiber! Vitamin D slows biological aging.
Leyla Muedin, a registered dietitian nutritionist in New York City, discusses the growing shift from symptom-only “sick care” to a clinically grounded holistic approach to health and recovery. She argues that self-guided wellness routines can leave gaps when underlying medical issues, mental health conditions, substance use disorders, or trauma remain unaddressed, and emphasizes integrating evidence-based clinical evaluation (including labs and deficiency testing) with lifestyle practices. She explains how treating symptoms in isolation misses connections (e.g., stress, sleep, grief) and defines true holistic care as addressing physical, mental, emotional, relational, environmental, and purpose-related factors without rejecting medical treatment. Key components include consistent movement, individualized nutrition built on basics, nervous system regulation (sleep, nature, breathing, meditation/prayer), meaningful social connection, and a sense of purpose as clinically relevant to resilience.
Naturopathic gastroenterologist Mark Davis, ND (FABNG), discusses his work in fecal microbiota transplantation (FMT), research, and integrative approaches to GI disease. Davis explains FMT history, screening criteria, delivery methods, how it differs from probiotics, and why it is highly effective for recurrent C. difficile (about a 90% durable cure), while noting FDA-approved products (Rebyota, Vowst) and off-label applications. He describes IRB-approved studies on naturopathic care for IBS and ulcerative colitis and a blinded project comparing consistency across 15–20 stool microbiome labs. The conversation covers evidence for diet in IBS/IBD (including SCD and a semi-vegetarian diet), low-FODMAP as a temporary tool, breath testing and relapse in SIBO, helminthic therapy options and legality, targeted probiotics (Saccharomyces boulardii, Akkermansia, soil-based species), enema therapies, indigo naturalis benefits and risks, saffron evidence for mood, telemedicine practice, and a crowdfunding platform for clinical trials.
Dr. Hoffman continues is conversation with naturopathic gastroenterologist Mark Davis, ND (FABNG).
Psychedelic Therapy for Mental Health: Research, Safety, and the Path to FDA Approval: Dr. Will Van Derveer and Keith Kurlander, co-authors of “Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life,” reveal the shift from recreational psychedelics to structured, research-based psychedelic-assisted therapy for conditions like PTSD, depression, and anxiety. Van Derveer describes limitations of conventional psychiatry (citing STAR*D remission rates) and his entry into MDMA-assisted PTSD research after promising results. They contrast controlled clinical protocols—screening, preparation, safe setting, trained facilitation, medical monitoring, and post-session integration—with uncontained recreational use. The discussion covers current policy momentum under Trump and RFK Jr., VA interest for veterans, and key agents: ketamine (including abuse risks and clinic-only Spravato), MDMA (phase 3 but not approved in 2024), psilocybin (phase 3, potential FDA approval), LSD (GAD trials), ibogaine (arrhythmia risk, Mexico clinics), ayahuasca, peyote, and microdosing. They also note commercialization, including Eli Lilly’s acquisition of a 5-MeO-DMT nasal spray developer, and emphasize an integrative “all-of-the-above” mental health approach.
From the publisher's feed
Ranked by our users in the last 21 days

772 Listeners

1,858 Listeners

7,184 Listeners

1,527 Listeners

1,999 Listeners

4,867 Listeners

3,420 Listeners

9,148 Listeners

1,798 Listeners

334 Listeners

133 Listeners

1,772 Listeners

833 Listeners

289 Listeners

1,222 Listeners